Exchange Traded Concepts LLC Sells 4,965 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Exchange Traded Concepts LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 40,666 shares of the medical equipment provider’s stock after selling 4,965 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Intuitive Surgical were worth $21,226,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Armistice Capital LLC lifted its position in shares of Intuitive Surgical by 65.7% in the second quarter. Armistice Capital LLC now owns 71,227 shares of the medical equipment provider’s stock valued at $31,685,000 after acquiring an additional 28,250 shares in the last quarter. AQR Capital Management LLC boosted its stake in Intuitive Surgical by 12.6% in the 2nd quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock worth $18,958,000 after purchasing an additional 4,775 shares during the period. APG Asset Management N.V. grew its holdings in Intuitive Surgical by 3.4% during the 2nd quarter. APG Asset Management N.V. now owns 234,279 shares of the medical equipment provider’s stock valued at $97,242,000 after buying an additional 7,648 shares in the last quarter. DE Burlo Group Inc. bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $4,982,000. Finally, Daymark Wealth Partners LLC boosted its position in shares of Intuitive Surgical by 3.6% during the second quarter. Daymark Wealth Partners LLC now owns 7,003 shares of the medical equipment provider’s stock worth $3,115,000 after acquiring an additional 246 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 42,475 shares of company stock worth $22,070,807. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 3.6 %

Shares of Intuitive Surgical stock opened at $586.72 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock’s fifty day moving average price is $544.61 and its 200-day moving average price is $502.64. The firm has a market cap of $208.98 billion, a P/E ratio of 94.01, a P/E/G ratio of 5.19 and a beta of 1.39.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. Raymond James boosted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday. BTIG Research increased their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $563.67.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.